KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Kardigan, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.94−0.09 (-0.69%)
Close on Oct 19, 2026
- Market cap
- $326.04M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 11, 2026 | Before market open | – | – | – |
Press releases
Announcements Kardigan filed with the SEC
Kardigan Announces Appointment of Kristin Reinke
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Results of operations · EX-99.1 to Form 8-K